FLEXION THERAPEUTICS INC - NOTE 3.375% 5/0

CUSIP: 33938JAB2

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class
Debt / NOTE 3.375% 5/0
Market price (% of par)
106.75%
Total 13F principal
$179,075,271
Principal change
+$14,648,271
Total reported market value
$191,174,159
Number of holders
21
Value change
+$15,929,722
Number of buys
12
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 33938JAB2?
CUSIP 33938JAB2 identifies 33938JAB2 - FLEXION THERAPEUTICS INC - NOTE 3.375% 5/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FLEXION THERAPEUTICS INC - NOTE 3.375% 5/0 as of Q4 2019

As of 31 Dec 2019, FLEXION THERAPEUTICS INC - NOTE 3.375% 5/0 was held by 21 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $179,075,271 in principal (par value) of the bond. The largest 10 bondholders included CITADEL ADVISORS LLC, Allianz Asset Management GmbH, SILVERBACK ASSET MANAGEMENT LLC, ZAZOVE ASSOCIATES LLC, CALAMOS ADVISORS LLC, Linden Advisors LP, ADVENT CAPITAL MANAGEMENT /DE/, WELLS FARGO & COMPANY/MN, OAKTREE CAPITAL MANAGEMENT LP, and FMR LLC. This page lists 21 institutional bondholders reporting positions for the Q4 2019 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.